In an era marked by unprecedented advances in technology, the intersection of AI, healthcare, and life sciences has paved the way for improved medical practice, research, and patient care. From predictive diagnostics to personalized treatment plans, AI is revolutionising how healthcare is delivered and experienced in the UK.
AI and Healthcare: key questions and answers Read More »
Brevia Health has deepened our vaccines expertise with the appointment of Nick Lowen as an Associate with over 30 years’ life sciences experience including serving as Vice President, Commercial Strategic Projects at GSK.
Brevia Health deepens vaccines expertise with Nick Lowen appointment Read More »
Brevia Health has appointed Mark Bassett as an Associate. Mark brings over 35 years of experience in healthcare advisory and leadership roles, including as Group Director of Public Policy at Bupa Group.
Mark Bassett joins Brevia Health Read More »
On 13 December 2023, NHS England announced an updated Vaccination Strategy following calls from pharmaceutical companies and trade bodies for a national Vaccination Strategy to tackle issues of accessibility, misinformation, and distrust around vaccination.
What is the NHS Vaccination Strategy? Read More »
On 30 January 2024, Wes Streeting MP, Shadow Secretary of State for Health and Social Care, and Peter Kyle MP, Shadow Secretary of State for Science, Innovation and Technology, launched Labour’s new Life Sciences Strategy at Stevenage Bioscience Catalyst. The new plan seeks to reform and modernise the NHS as well as capture the economic potential in the life sciences sector, supporting one of Labour’s key missions for the UK to have the highest sustained growth in the G7.
What is Labour’s Life Sciences Plan? Read More »
The UK’s political parties held their annual Party Conferences in September and October this year. They provided an opportunity to promote their policies and outline their respective political agendas ahead of the upcoming general election.
Health at the Party Conferences 2023: Key Questions and Answers Read More »
The UK Health Security Agency (UKHSA) has agreed to a deal for millions of life-saving vaccines to be produced in the UK if a future influenza pandemic is ever declared.
UKHSA UK-based vaccine deal: key questions and answers Read More »
The UKHSA 10-year Science Strategy sets out how the UK Government will prepare and respond to future health security hazards and current threats to save lives. The new plan, Securing health and prosperity, examines how the UK can utilise its scientific capabilities – including genomics, data science, and diagnostics – to reduce harm, protect livelihoods and strengthen the overall capacity of health security.
UKHSA launches 10-year Science Strategy: key questions and answers Read More »
Brevia Health has appointed Jonathan Mogford to its Advisory Board. Jonathan brings a career’s experience of health, life sciences and regulation, both nationally and internationally, including more than 10 years corporate executive leadership as Policy Director in the UK Medicines and Healthcare products Regulatory Agency (MHRA), alongside wider experience in the Department of Health and Social Care, and the European Commission.
Jonathan Mogford joins Brevia Health Read More »
The Health and Social Care Committee has published a new report on Integrated Care Systems (ICSs), calling for the Government and NHS England to address key concerns if an opportunity to deliver real change is to be achieved.
5 Salamanca Place, London SE1 7HP
Phone: +44(0) 20 7091 1650
Email: contact@brevia.co.uk
